Synthesis of magnetic gold coated poly (?-caprolactonediol) based polyurethane/poly(N-isopropylacrylamide)-grafted-chitosan core-shell nanofibers for controlled release of paclitaxel and 5-FU

dc.contributor.authorFarboudi, Amirnezam
dc.contributor.authorNouri, Arezo
dc.contributor.authorShirinzad, Sara
dc.contributor.authorSojoudi, Parsa
dc.contributor.authorDavaran, Soodabeh
dc.contributor.authorAkrami, Mohammad
dc.contributor.authorIrani, Mohammad
dc.date.accessioned2026-02-06T18:38:13Z
dc.date.issued2020
dc.departmentDoğu Akdeniz Üniversitesi
dc.description.abstractThe poly (epsilon-caprolactonediol) based polyurethane (PCL-Diol-b-PU)/poly(N-isopropylacrylamide)-grafted-chitosan (PNIPAAm-g-chitosan) core-shell nanofibers were synthesized via coaxial electrospinning process. Paclitaxel and 5-FU anticancer drugs were incorporated into the core of nanofibers. The nanofibers surface was coated using magnetic gold nanoparticles and the potential of synthesized nanofibers was investigated for the sustained release of paclitaxel and 5-FU toward 4T1 breast cancer cells death in vitro and in vivo. The synthesized magnetic nanoparticles were characterized using SEM, TEM, XRD and DLS analysis. The surface morphology of nanofibers was studied under various applied voltage and different shell flow rates. The paclitaxel and 5-FU release profiles from nanofibers were examined under acidic and physiological pH. The maximum 4T1 cell killing was found to be 78% using magnetic gold coated-nanofibers in the presence of external magnetic field. The SEM images after incubation of nanofibers in 4T1 breast cancer cells indicated the well adhesion of cells on the nanofibers surface. The in vivo studies showed that the tumor volume did not change during 10 days. The minimum increase in tumor volume was obtained using paclitaxel and 5-FU loaded-nanofibers coated by the magnetic gold nanoparticles. The obtained results demonstrated the high therapeutic efficiency of synthesized nanofibrous carrier toward breast cancer treatment. (C) 2019 Elsevier B.V. All rights reserved.
dc.identifier.doi10.1016/j.ijbiomac.2019.10.120
dc.identifier.endpage1140
dc.identifier.issn0141-8130
dc.identifier.issn1879-0003
dc.identifier.orcid0000-0002-6180-8412
dc.identifier.pmid31705906
dc.identifier.scopus2-s2.0-85075340468
dc.identifier.scopusqualityQ1
dc.identifier.startpage1130
dc.identifier.urihttps://doi.org/10.1016/j.ijbiomac.2019.10.120
dc.identifier.urihttps://hdl.handle.net/11129/12837
dc.identifier.volume150
dc.identifier.wosWOS:000525869500114
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofInternational Journal of Biological Macromolecules
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260204
dc.subjectPCL-Diol-b-PU
dc.subjectPNIPAAm-g-chitosan
dc.subjectCore-shell nanofiber
dc.subjectBreast cancer
dc.subjectIn vivo
dc.titleSynthesis of magnetic gold coated poly (?-caprolactonediol) based polyurethane/poly(N-isopropylacrylamide)-grafted-chitosan core-shell nanofibers for controlled release of paclitaxel and 5-FU
dc.typeArticle

Files